Table 1.
Summary of patient characteristics.
| Name | Sex | Age (years) | Surgical staging | Type of surgery | Surgical pathology | Interval between surgery and recurrence (months) | Interval between surgery and SBRT (months) | ECOG | Symptoms | Synchronous metastases |
|---|---|---|---|---|---|---|---|---|---|---|
| LZJ | Male | 46 | T3N0M0 | R0 | Sarcomatoid carcinoma | 1.3 | 1.7 | 2 | Abdominal pain | Liver |
| WBH | Male | 71 | T3N1M0 | R0 | Adenocarcinoma | 10.5 | 13.6 | 1 | No | |
| LB | Male | 56 | T3N1M0 | R1 | Mucinous adenocarcinoma | 13.1 | 16.2 | 1 | No | |
| SXG | Male | 50 | T3N2M0 | R0 | Adenocarcinoma | 10.6 | 11.5 | 3 | Abdominal pain | |
| HXQ | Male | 47 | T4N0M0 | R2 | Adenocarcinoma | 0 | 4.5 | 1 | Abdominal pain | |
| WMH | Female | 61 | T4N0M0 | R0 | Adenocarcinoma | 11.2 | 12.3 | 2 | Lumbago | |
| ZXS | Male | 72 | T2N0M0 | R0 | Adenocarcinoma | 34.2 | 37.2 | 2 | Abdominal pain | |
| LQB | Male | 68 | T2N1M0 | R0 | Adenocarcinoma | 6.4 | 11.5 | 1 | No | |
| ZQ | Female | 70 | T3N0M0 | R0 | Adenocarcinoma | 10.5 | 12.3 | 1 | No | |
| WDC | Male | 69 | T1N0M0 | R0 | Adenocarcinoma | 11.4 | 23.3 | 1 | Lumbago | |
| ZH | Female | 48 | T3N1M0 | R0 | Adenocarcinoma | 14.3 | 19.9 | 3 | Lumbago | |
| YCH | Male | 80 | T3N1M0 | R0 | Adenocarcinoma with focal squamous cell carcinoma | 4 | 5.4 | 2 | No | |
| WZJ | Male | 69 | T3N0M0 | R0 | Adenocarcinoma | 19 | 22 | 1 | Abdominal pain | |
| LYM | Female | 53 | T3N1M0 | R0 | Adenocarcinoma | 5.5 | 6.9 | 3 | No | Lymphonodus of neck and armpit |
| ZL | Male | 43 | T3N0M0 | R1 | Adenocarcinoma | 5.3 | 5.8 | 1 | No | |
| WWJ | Male | 79 | T2N2M0 | R0 | Adenocarcinoma | 10.9 | 11.5 | 2 | No | |
| GLY | Female | 81 | T1N0M0 | R0 | Adenocarcinoma | 10 | 10.9 | 2 | Abdominal pain | |
| SST | Male | 51 | T3N0M0 | R0 | Adenocarcinoma | 4.7 | 5.8 | 1 | Abdominal pain and anorexia | |
| LW | Male | 50 | T4N1M0 | R0 | Adenocarcinoma | 6 | 6.4 | 1 | Abdominal pain | |
| XGD | Male | 53 | T3N0M0 | R0 | Adenocarcinoma | 15.4 | 17.6 | 1 | Lumbago | |
| ZJB | Male | 53 | T4N1M0 | R2 | Adenocarcinoma | 0 | 2.3 | 1 | Abdominal pain | |
| CQH | Female | 60 | T4N1M0 | R0 | Adenocarcinoma | 3.7 | 8.6 | 2 | No | |
| GHL | Female | 74 | T3N1M0 | R0 | Adenocarcinoma | 9 | 10.6 | 2 | Abdominal pain | |
| XZ | Male | 73 | T3N2M0 | R0 | Adenocarcinoma | 7.7 | 8.3 | 2 | Abdominal pain | |
| WHM | Female | 56 | T2N1M0 | R0 | Adenocarcinoma | 10 | 12 | 1 | Abdominal pain | |
| LAG | Male | 56 | T3N1M0 | R0 | Adenocarcinoma | 12.2 | 13 | 1 | Lumbago | |
| WYZ | Female | 62 | T2N0M0 | R0 | Adenocarcinoma | 7 | 7.6 | 1 | No |
Abbreviations: SBRT, stereotactic body radiation therapy.
Note: The R0, R1 and R2 were defined as negative margins, microscopically positive margins, and macroscopically positive margins after surgery, respectively.